Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer 2024-05-13 22:00
ObeEnd - Pioneering Drug-Free Weight Management Wristband 2024-05-13 21:00
Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention 2024-05-11 15:14
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of Autoimmune Diseases of the Central Nervous System Published in Science Immunology 2024-05-11 10:16
Zepp Health Corporation Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price 2024-05-11 05:00
Momcozy Celebrates Motherhood with "Momcozy Village" Event at Babylist Beverly Hills 2024-05-10 22:00
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering 2024-05-10 21:20
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound) 2024-05-10 20:07
Nuvilab Becomes B Corp Certified 2024-05-10 19:59
Ribobay Pharma boosts CRDMO offerings with Cytiva's first FlexFactory platform for oligonucleotides 2024-05-10 18:39
WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval 2024-05-10 12:16
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer 2024-05-10 12:00
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition cost 2024-05-10 07:41
FDA Clears the Individualized Nomogram for Rika Plasma Donation System 2024-05-09 20:00
Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines 2024-05-09 15:30
Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery 2024-05-09 15:00
Front Street Re Appoints Edison Fong as Chief Executive Officer 2024-05-08 21:22
NeuShen Therapeutics Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric Modulator for the Treatment of Schizophrenia 2024-05-08 21:00
TiumBio Announces Positive Topline Data from Phase 2a Trial of Merigolix in Patients with Moderate to Severe Endometriosis-Associated Pain 2024-05-08 20:00
Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting 2024-05-08 18:18
1 34 35 36 37 38 800